Who owns Oncolytics Biotech Inc?

Tip: Access positions for across all investors

Analyze quarterly positions in Oncolytics Biotech with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Oncolytics Biotech stock

Who bought or sold Oncolytics Biotech Inc this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of Actions
Sandbox Financial Partners 400k $340k 100% Mar 2026
 View chart
Marshall Wace 262k $228k -19% Dec 2025
 View chart
Seeds Investor 258k $226k 0% Dec 2025
 View chart
International Assets Investment Management 208k $182k 1% Dec 2025
 View chart
Goldman Sachs Group 170k $149k -19% Dec 2025
 View chart
Connective Capital Management 150k $131k 100% Dec 2025
 View chart
Everhart Financial Group 138k $117k 100% Mar 2026
 View chart
Doliver Capital Advisors 100k $85k 100% Mar 2026
 View chart
XTX Topco 79k $69k 100% Dec 2025
 View chart
Virtu Financial 78k $68k 100% Dec 2025
 View chart
Tocqueville Asset Management 72k $63k 100% Dec 2025
 View chart
CIBC World Markets 70k $61k 17% Dec 2025
 View chart
Franklin Resources 70k $72k 0% Dec 2025
 View chart
Geode Capital Management 67k $59k 0% Dec 2025
 View chart
Atlantic Trust 50k $44k 100% Dec 2025
 View chart
Headinvest 45k $39k 0% Dec 2025
 View chart
LPL Financial 40k $35k -21% Dec 2025
 View chart
Ball & Co Wealth Management 38k $33k 0% Dec 2025
 View chart
Commonwealth Equity Services 35k $31k 40% Dec 2025
 View chart
Raymond James Financial 33k $29k 100% Dec 2025
 View chart
Security National Bank Of Sioux City Iowa 33k $29k 100% Dec 2025
 View chart
SeaCrest Wealth Management 32k $27k 0% Mar 2026
 View chart
Federation des caisses Desjardins du Quebec 32k $28k 0% Dec 2025
 View chart
William Blair $ Company 32k $28k 100% Dec 2025
 View chart
Vantage Point Financial 30k $26k 0% Dec 2025
 View chart
National Bank Of Canada /fi/ 25k $22k 0% Dec 2025
 View chart
PFG Investments 23k $20k 12% Dec 2025
 View chart
UBS Group 23k $20k 0% Dec 2025
 View chart
AlphaCore Capital 23k $20k 100% Dec 2025
 View chart
Rockefeller Capital Management 21k $18k 0% Dec 2025
 View chart
Professional Advisory Services 20k $17k 0% Mar 2026
 View chart
Pnc Financial Services 15k $13k 0% Dec 2025
 View chart
Jane Street 14k $14k -33% Dec 2025
 View chart
Creative Planning 13k $12k 0% Dec 2025
 View chart
Ausdal Financial Partners 12k $11k 0% Dec 2025
 View chart
Hrt Financial 12k $10k -39% Dec 2025
 View chart
Kingsview Wealth Management 11k $9.8k 0% Dec 2025
 View chart
HPM Partners 10k $8.7k 0% Dec 2025
 View chart
Hanson McClain Advisors 8.5k $7.4k 0% Dec 2025
 View chart
Cedar Mountain Advisors 5.7k $4.9k 0% Dec 2025
 View chart
Advisor Group Holdings 5.6k $4.8k 8730% Dec 2025
 View chart
Wells Fargo & Company 5.4k $4.7k 23% Dec 2025
 View chart
Activest Wealth Management 5.0k $4.2k 0% Mar 2026
 View chart
BlackRock 3.0k $2.6k 0% Dec 2025
 View chart
Jones Financial Companies, L.L 2.1k $1.8k 0% Dec 2025
 View chart
CWM 1.3k $999.977500 0% Dec 2025
 View chart
MAI Wealth Advisors 526.00 $459.987000 0% Dec 2025
 View chart
TD Waterhouse Canada 400.00 $353.000000 0% Dec 2025
 View chart
JNBA Financial Advisors 210.00 $184.002000 0% Dec 2025
 View chart
Sound Income Strategies 194.00 $195.998200 0% Dec 2025
 View chart
Dogwood Wealth Management 146.00 $127.998200 0% Dec 2025
 View chart
Aviso Financial 52.00 $45.000800 0% Dec 2025
 View chart

Who sold out of Oncolytics Biotech?

Fund or Company Name Date Sold Shares Held Valued At
Citadel Advisors Sep 2025 382k $535k
Badgley Phelps Wealth Managers Dec 2025 40k $35k
Ground Swell Capital Dec 2025 34k $30k
Brave Asset Management Dec 2025 25k $22k
Cambridge Investment Research Advisors Sep 2025 25k $35k
Financial Advisory Corp Sep 2025 21k $29k
Scientech Research Sep 2025 18k $26k
Huntleigh Advisors Dec 2025 13k $11k
Valley National Advisers Dec 2025 7.0k $6.0k
Bnp Paribas Arbitrage, Snc Sep 2025 2.9k $4.0k